Bipartisan efforts to legislate pharmaceutical patent reform are heating up David Mitchell, president and organizer behind Patients for Reasonable Medications, tunes in during a Senate hearing … [+] Legal executive Panel hearing on licensed innovation and physician recommended drug evaluating in Washington, DC. Administrators need to examine whether medication organizations are mishandling government regulations to broaden the existence of their licenses and battle off rivalry from nonexclusive and biosimilar drugs. Picture taker: Melissa Lyttle/Bloomberg https://blogaid.org/bipartisan-efforts-to-legislate-pharmaceutical-patent-reform-are-heating-up/